Dr. Joel Dudley Named one of "The 100 Most Creative People in Business 2014" by Fast Company
Joel Dudley, PhD, Assistant Professor of Genetics and Genomic Sciences and Director of Biomedical Informatics at the Icahn School of Medicine at Mount Sinai, is featured in the June 2014 issue of Fast Company magazine as one of "The 100 Most Creative People in Business." Dr. Dudley is ranked #41 on the list for "splicing information with quality medical care." The editors highlighted Dr. Dudley’s innovative use of network modeling to predict which cancer therapies could be most effective.
Mount Sinai Genetic Testing Laboratory Nearly Doubles Diseases Covered by Ashkenazi Jewish Carrier Screening Panel
May 8, 2014 - With expanded screening test, 50 percent of Ashkenazi Jewish individuals are expected to be identified as carriers of at least one of the 38 diseases.
Mount Sinai Scientists Identify First Gene Linked to Heart Muscle Disease in Children
April 28, 2014 - Findings show several FDA-approved drugs may also be effective in patients diagnosed with dilated cardiomyopathy.
Scientists Reveal New Findings for Reversing Early and Late Atherosclerosis
February 28, 2014 - Icahn School of Medicine at Mount Sinai study suggests early-stage atherosclerosis is reversible, and identifies new genetic targets for fighting advanced atherosclerosis.